Leptin as a Modulator of Neuroendocrine Function in Humans

DSpace/Manakin Repository

Leptin as a Modulator of Neuroendocrine Function in Humans

Citable link to this page


Title: Leptin as a Modulator of Neuroendocrine Function in Humans
Author: Khan, Sami M.; Brinkoetter, Mary; Hamnvik, Ole-Petter Riksfjord; Mantzoros, Christos

Note: Order does not necessarily reflect citation order of authors.

Citation: Khan, Sami M., Ole-Petter R. Hamnvik, Mary Brinkoetter, and Christos S. Mantzoros. 2012. Leptin as a modulator of neuroendocrine function in humans. Yonsei Medical Journal 53(4): 671-679.
Full Text & Related Files:
Abstract: Leptin, a peptide hormone secreted by adipocytes in proportion of the amount of energy stored in fat, plays a central role in regulating human energy homeostasis. In addition, leptin plays a significant permissive role in the physiological regulation of several neuroendocrine axes, including the hypothalamic-pituitary-gonadal, -thyroid, -growth hormone, and -adrenal axes. Decreased levels of leptin, also known as hypoleptinemia, signal to the brain a state of energy deprivation. Hypoleptinemia can be a congenital or acquired condition, and is associated with alterations of the aforementioned axes aimed at promoting survival. More specifically, gonadotropin levels decrease and become less pulsatile under conditions of energy deprivation, and these changes can be at least partially reversed through leptin administration in physiological replacement doses. Similarly, leptin deficiency is associated with thyroid axis abnormalities including abnormal levels of thyrotropin-releasing hormone, and leptin administration may at least partially attenuate this effect. Leptin deficiency results in decreased insulin-like growth factor 1 levels which can be partially ameliorated through leptin administration, and leptin appears to have a much more pronounced effect on the growth of rodents than that of humans. Similarly, adrenal axis function is regulated more tightly by low leptin in rodents than in humans. In addition to congenital leptin deficiency, conditions that may be associated with decreased leptin levels include hypothalamic amenorrhea, anorexia nervosa, and congenital or acquired lipodystrophy syndromes. Accumulating evidence from proof of concept studies suggests that leptin administration, in replacement doses, may ameliorate neuroendocrine abnormalities in individuals who suffer from these conditions.
Published Version: doi:10.3349/ymj.2012.53.4.671
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381496/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10445611
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search